Connor, Clark & Lunn Investment Management Ltd. Atri Cure, Inc. Transaction History

Connor, Clark & Lunn Investment Management Ltd.

$21.1 Billion
Q1 2025

A detailed history of Connor, Clark & Lunn Investment Management Ltd. transactions in Atri Cure, Inc. stock. As of the latest transaction made, Connor, Clark & Lunn Investment Management Ltd. holds 223,569 shares of ATRC stock, worth $7.5 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

223,569

Previous 181,722 23.03%

Holding current value

$7.5 Million

Previous $5.55 Million 29.88%

% of portfolio

0.03%

Previous 0.03%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 12, 2025	BUY	$30.4 - $42.4 $1.27 Million - $1.77 Million	41,847 Added 23.03%	223,569 $7.21 Million
Q4 2024 Feb 10, 2025	SELL	$27.02 - $38.2 $110,700 - $156,505	-4,097 Reduced 2.2%	181,722 $5.55 Million
Q3 2024 Nov 08, 2024	BUY	$20.34 - $29.5 $1.07 Million - $1.55 Million	52,533 Added 39.41%	185,819 $5.21 Million
Q2 2024 Aug 09, 2024	BUY	$19.86 - $29.09 $1.12 Million - $1.64 Million	56,380 Added 73.31%	133,286 $3.03 Million
Q1 2024 May 09, 2024	BUY	$28.21 - $37.78 $1.14 Million - $1.53 Million	40,559 Added 111.59%	76,906 $2.34 Million
Q4 2023 Feb 09, 2024	BUY	$32.99 - $43.25 $536,384 - $703,201	16,259 Added 80.94%	36,347 $1.3 Million
Q3 2023 Nov 13, 2023	SELL	$41.12 - $57.73 $1.63 Million - $2.28 Million	-39,560 Reduced 66.32%	20,088 $879,000
Q2 2023 Aug 10, 2023	BUY	$40.44 - $49.6 $648,374 - $795,236	16,033 Added 36.76%	59,648 $2.94 Million
Q1 2023 May 09, 2023	BUY	$35.87 - $47.22 $550,999 - $725,346	15,361 Added 54.37%	43,615 $1.81 Million
Q4 2022 Feb 10, 2023	BUY	$33.48 - $47.45 $494,365 - $700,646	14,766 Added 109.48%	28,254 $1.25 Million
Q3 2022 Nov 10, 2022	BUY	$38.25 - $52.62 $515,916 - $709,738	13,488 New	13,488 $527,000
Q3 2021 Nov 12, 2021	SELL	$69.28 - $84.46 $445,193 - $542,739	-6,426 Closed	0 $0
Q2 2021 Aug 12, 2021	BUY	$64.13 - $80.18 $412,099 - $515,236	6,426 New	6,426 $510,000
Q4 2018 Feb 12, 2019	SELL	$26.66 - $34.85 $159,960 - $209,100	-6,000 Closed	0 $0
Q3 2018 Nov 13, 2018	BUY	$27.62 - $35.58 $165,720 - $213,480	6,000 New	6,000 $210,000

Others Institutions Holding ATRC

# of Institutions

238

Shares Held

52M

Call Options Held

32.6K

Put Options Held

4.5K

View Full List

About AtriCure, Inc.

Ticker ATRC
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 46,424,700
Market Cap $1.56B
Description
AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally. The company offers Isolator Synergy Clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation...

More about ATRC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Connor, Clark & Lunn Investment Management Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Connor, Clark & Lunn Investment Management Ltd. with notifications on news.

Account

Connor, Clark & Lunn Investment Management Ltd. Atri Cure, Inc. Transaction History